Publicaciones en las que colabora con Juan Manuel de Gandarias Bajón (52)

2010

  1. Evaluación de los datos obtenidos sobre factores de riesgo cardiovascular en las Semanas de Prevención de la Arteriosclerosis y Enfermedades Cardiovasculares (2000-2008)

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 107, Núm. 3, pp. 84-89

2000

  1. Lithium alters mu-opioid receptor expression in the rat brain

    Neuroscience Letters, Vol. 279, Núm. 1, pp. 9-12

  2. Subcellular distribution of pyroglutamyl-peptidase I activity in the developing rat cerebellum

    Developmental Neuroscience, Vol. 22, Núm. 4, pp. 264-273

  3. Subcellular ontogeny of brain pyroglutamyl peptidase I

    Peptides, Vol. 21, Núm. 4, pp. 509-517

1999

  1. Effect of imipramine on enkephalin-degrading peptidases

    European Neuropsychopharmacology, Vol. 9, Núm. 6, pp. 493-499

  2. Effect of lithium treatments on the tyrosine-aminopeptidase activities in the rat brain and the pituitary gland

    Arzneimittel-Forschung/Drug Research, Vol. 49, Núm. 10, pp. 816-819

  3. Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain

    Brain Research, Vol. 817, Núm. 1-2, pp. 236-240

  4. Infraorbital Nerve Transection Increases NADPH-diaphorase Activity in the Rat Mesencephalic Trigeminal Nucleus

    Journal of Brain Research, Vol. 39, Núm. 4, pp. 567-571

  5. Ontogeny of puromycin-sensitive and insensitive aminopeptidase activities in several subcellular fractions of the rat brain

    Brain Research Bulletin, Vol. 50, Núm. 4, pp. 283-290

1998

  1. Effects of acute lidocaine administration on the rat prosencephalic enkephalinergic system

    Journal of Brain Research, Vol. 39, Núm. 1, pp. 3-7

  2. Effects of imipramine administration on μ-opioid receptor immunostaining in the rat forebrain

    Arzneimittel-Forschung/Drug Research, Vol. 48, Núm. 7, pp. 717-719

  3. Polyploidization and exit from cell cycle as mechanisms of cultured melanoma cell resistance to methotrexate

    Life Sciences, Vol. 62, Núm. 25, pp. 2275-2282

  4. Soluble and membrane-bound pyroglutamyl-peptidase I activity in the developing cerebellum and brain cortex

    International Journal of Developmental Biology, Vol. 42, Núm. 1, pp. 103-106

1997

  1. Effect of lidocaine administration on the enkephalin- degrading aminopeptidase activities in discrete areas of the rat brain

    General Pharmacology, Vol. 29, Núm. 3, pp. 489-493

  2. Interaction mechanisms of imipramine and desipramine with enkephalin-degrading aminopeptidases in vitro

    Life Sciences, Vol. 61, Núm. 21

  3. Subcellular analysis of Tyr-aminopeptidase activities in the developing rat cerebellum

    Developmental Brain Research, Vol. 99, Núm. 1, pp. 66-71

1996

  1. Age-related changes in the soluble and the membrane-bound Tyr-aminopeptidase activities in several areas of the male and female rat brain

    Reproduction, Fertility and Development, Vol. 8, Núm. 3, pp. 465-469

  2. Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34cdc2, cyclin B1, PCNA and 3[H]-thymidine

    Cell Proliferation, Vol. 29, Núm. 2, pp. 89-100

  3. Membrane-bound tyrosine aminopeptidase activities in the rat brain throughout the estrous cycle

    Life Sciences, Vol. 59, Núm. 13, pp. 1097-1101

1995

  1. Acid, basic and neutral soluble and membrane-bound aminopeptidase activities after lidocaine administration in discrete areas of the rat brain

    Journal of Brain Research, Vol. 36, Núm. 3, pp. 349-352